Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.8B | 8.7B | 7.4B | 8.7B |
Cost of revenue | 7.0B | 6.0B | 4.9B | 5.4B |
Gross profit | 3.8B | 2.7B | 2.5B | 3.3B |
Operating expense | ||||
Research & development | 102.8M | 71.9M | 286.2M | 301.4M |
Selling general and admin | 305.1M | -461.8M | 587.7M | -91.5M |
Other operating expenses | 127.7M | 169.0M | 171.9M | 166.5M |
Operating income | 3.3B | 2.2B | 1.8B | 2.6B |
Non operating interest income | ||||
Income | 12.2M | 6.1M | 8.4M | 5.7M |
Expense | 245.7M | 152.3M | 195.5M | 213.9M |
Other income expense | — | — | — | — |
Pretax income | 2.8B | 2.0B | 1.4B | 2.2B |
Tax provision | 389.5M | 167.3M | 185.8M | 353.3M |
Net income | 2.4B | 1.8B | 1.2B | 1.9B |
Basic EPS | 0.3 | — | — | — |
Diluted EPS | 0.3 | — | — | — |
Basic average shares | 7.4B | — | — | — |
Diluted average shares | 7.4B | — | — | — |
EBITDA | 3.1B | 2.1B | 1.6B | 2.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |